Skip to main content

Table 1 Profile of Herpes Zoster Cases by Varicella Vaccine Availability, BC 1997–2012

From: Increasing incidence associated with herpes zoster infection in British Columbia, Canada

  Pre-licensure Privately Funded Publicly Funded Overall
  1997–1998 1999–2004 2005–2012 1997–2012
Age
 0–9 1577 (6.7 %) 4562 (5.9 %) 3619 (2.6 %) 9758 (4.1 %)
 10–19 1422 (6 %) 4649 (6.1 %) 6995 (5.1 %) 13066 (5.5 %)
 20–29 2073 (8.8 %) 6314 (8.2 %) 11706 (8.5 %) 20093 (8.4 %)
 30–39 2952 (12.5 %) 8743 (11.4 %) 13304 (9.7 %) 24999 (10.5 %)
 40–49 3098 (13.1 %) 10550 (13.7 %) 17872 (13 %) 31520 (13.2 %)
 50–59 3332 (14.1 %) 12544 (16.3 %) 25707 (18.7 %) 41583 (17.5 %)
 60–69 3397 (14.4 %) 11306 (14.7 %) 25270 (18.3 %) 39973 (16.8 %)
 70–79 3682 (15.6 %) 11049 (14.4 %) 19552 (14.2 %) 34283 (14.4 %)
 80+ 2089 (8.8 %) 7149 (9.3 %) 13738 (10 %) 22976 (9.6 %)
 Unknown 12 (0.1 %) 24 (0 %) 8 (0 %) 44 (0 %)
 Mean (IQR) 49.6 (33–69) 50.2 (34–69) 53.2 (39–69) 51.9 (36–69)
Gender
 Male 10141 (42.9 %) 32247 (41.9 %) 56917 (41.3 %) 99305 (41.7 %)
 Female 13453 (56.9 %) 44579 (58 %) 80823 (58.7 %) 138855 (58.3 %)
 Unknown 40 (0.2 %) 64 (0.1 %) 31 (0 %) 135 (0.1 %)
Health Authority
 Interior 4040 (17.1 %) 13659 (17.8 %) 24215 (17.6 %) 41914 (17.6 %)
 Fraser 7470 (31.6 %) 24894 (32.4 %) 43316 (31.4 %) 75680 (31.8 %)
 Vancouver Coastal 5684 (24.1 %) 17632 (22.9 %) 33518 (24.3 %) 56834 (23.9 %)
 Island 4264 (18 %) 14231 (18.5 %) 26046 (18.9 %) 44541 (18.7 %)
 Northern 1174 (5.0 %) 3667 (4.8 %) 7902 (5.7 %) 12743 (5.4 %)
 Unknown 1002 (4.2 %) 2807 (3.7 %) 2774 (2 %) 6583 (2.8 %)
Immunosuppression Status (Any)
 Yes 905 (3.8 %) 3121 (4.1 %) 5500 (4.0 %) 9526 (4.0 %)
 No 22729 (96.2 %) 73769 (95.9 %) 132271 (96.0 %) 228769 (96.0 %)
Zoster Vaccinated
 Yes NA NA 516 (0.4 %) 516 (0.2 %)
 No 23634 (100 %) 76890 (100 %) 137255 (99.6 %) 237779 (99.8 %)